{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:02:49Z","timestamp":1793278969102,"version":"4.5.0"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Bone metastasis is closely related to the survival rate of cancer patients and reduces their quality of life. The bone marrow microenvironment contains a complex immune cell component with a local microenvironment that is conducive to tumor formation and growth. In this unique immune environment, a variety of immune cells, including T cells, natural killer cells, macrophages, dendritic cells, and myeloid-derived suppressor cells, participate in the process of bone metastasis. In this review, we will introduce the interactions between immune cells and cancer cells in the bone microenvironment, obtain the details of their contributions to the implications of bone metastasis, and discuss immunotherapeutic strategies targeting immune cells in cancer patients with bone metastasis.<\/jats:p>","DOI":"10.3389\/fendo.2022.1019864","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T06:49:41Z","timestamp":1664434181000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Contribution of immune cells to bone metastasis pathogenesis"],"prefix":"10.3389","volume":"13","author":[{"given":"Ningning","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","volume":"12","author":"Coleman","year":"2006","journal-title":"Clin Cancer Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/143526","article-title":"The impact of immune system in regulating bone metastasis formation by osteotropic tumors","volume":"2015","author":"D'Amico","year":"2015","journal-title":"J Immunol Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-07-0234","article-title":"Molecular biology of bone metastasis","volume":"6","author":"Kingsley","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"B4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40425-017-0283-9","article-title":"The immune system in cancer metastasis: Friend or foe","volume":"5","author":"Janssen","year":"2017","journal-title":"J Immunother Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10555-007-9109-4","article-title":"The bone microenvironment in metastasis; what is special about bone","volume":"27","author":"Bussard","year":"2008","journal-title":"Cancer Metastasis Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.3390\/ijms20163899","article-title":"The mode-of-Action of targeted alpha therapy radium-223 as an enabler for novel combinations to treat patients with bone metastasis","volume":"20","author":"Suominen","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.0841","article-title":"Pathogenesis and treatment of prostate cancer bone metastases: Targeting the lethal phenotype","volume":"23","author":"Loberg","year":"2005","journal-title":"J Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3910","article-title":"Metastasis prevention by targeting the dormant niche","volume":"15","author":"Ghajar","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2014.02.002","article-title":"Metastatic stem cells: Sources, niches, and vital pathways","volume":"14","author":"Oskarsson","year":"2014","journal-title":"Cell Stem Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: Suppression of breast tumor growth and metastasis by novel carbonic anhydrase ix inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0805239","article-title":"Molecular basis of metastasis","volume":"359","author":"Chiang","year":"2008","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2969","article-title":"Vascular niche e-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance","volume":"18","author":"Winkler","year":"2012","journal-title":"Nat Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002856","article-title":"Il-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cells","volume":"9","author":"Magidey-Klein","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.22402","article-title":"Expression pattern of receptor activator of nfkappab (Rank) in a series of primary solid tumors and related bone metastases","volume":"226","author":"Santini","year":"2011","journal-title":"J Cell Physiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1600-0765.2010.01306.x","article-title":"Effect of bisphosphonates on the production of mediators of osteoclastogenesis (Rankl, opg, and il-6) by human gingival fibroblasts","volume":"46","author":"Tipton","year":"2011","journal-title":"J Periodontal Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M804812200","article-title":"Interferon-gamma targets cancer cells and osteoclasts to prevent tumor-associated bone loss and bone metastases","volume":"284","author":"Xu","year":"2009","journal-title":"J Biol Chem"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068171","article-title":"T Cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancer","volume":"8","author":"Monteiro","year":"2013","journal-title":"PloS One"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/925135","article-title":"Cd4(+)T cells: Differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27553","article-title":"Contribution of regulatory T cells to cancer: A review","volume":"234","author":"Najafi","year":"2019","journal-title":"J Cell Physiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4161\/onci.1.2.18480","article-title":"Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer","volume":"1","author":"Zhao","year":"2012","journal-title":"Oncoimmunology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nature09707","article-title":"Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through rankl-rank signalling","volume":"470","author":"Tan","year":"2011","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.824117","article-title":"Roles of the rankl-rank axis in immunity-implications for pathogenesis and treatment of bone metastasis","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3390\/cancers12041014","article-title":"Contribution of macrophages and T cells in skeletal metastasis","volume":"12","author":"Mendoza-Reinoso","year":"2020","journal-title":"Cancers"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00372","article-title":"Human plasmacytoid dendritic cells: From molecules to intercellular communication network","volume":"4","author":"Mathan","year":"2013","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4615","article-title":"Bone microenvironment-suppressed T cells increase osteoclast formation and osteolytic bone metastases in mice","volume":"37","author":"Arellano","year":"2022","journal-title":"J Bone Miner Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1318731111","article-title":"Human memory T cells from the bone marrow are resting and maintain long-lasting systemic memory","volume":"111","author":"Okhrimenko","year":"2014","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.01.008","article-title":"Bone marrow is a major reservoir and site of recruitment for central memory Cd8+ T cells","volume":"22","author":"Mazo","year":"2005","journal-title":"Immunity"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030725","article-title":"Il-7 promotes the transition of Cd4 effectors to persistent memory cells","volume":"198","author":"Li","year":"2003","journal-title":"J Exp Med"},{"key":"B29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/1097-0215(200102)9999:9999<::AID-IJC1152>3.0.CO;2-Q","article-title":"Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients","volume":"92","author":"Feuerer","year":"2015","journal-title":"Int J Cancer J Int Du Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nature13989","article-title":"Tissue-resident macrophages originate from yolk-Sac-Derived erythro-myeloid progenitors","volume":"518","author":"Gomez Perdiguero","year":"2015","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.21.2.0395","article-title":"Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","author":"Manolagas","year":"2000","journal-title":"Endocr Rev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/pin.12440","article-title":"Role of tumor-associated macrophages in human malignancies: Friend or foe","volume":"66","author":"Takeya","year":"2016","journal-title":"Pathol Int"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.06.007","article-title":"Cavity macrophages stop anti-tumor T cells","volume":"39","author":"Rodriguez","year":"2021","journal-title":"Cancer Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.ccell.2021.05.006","article-title":"Tim-4(+) cavity-resident macrophages impair anti-tumor Cd8(+) T cell immunity","volume":"39","author":"Chow","year":"2021","journal-title":"Cancer Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nature10138","article-title":"Ccl2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2012","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s10911-014-9320-1","article-title":"Csf-1r signaling in health and disease: A focus on the mammary gland","volume":"19","author":"Sullivan","year":"2014","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1124\/mol.64.3.773","article-title":"Signaling pathways for monocyte chemoattractant protein 1-mediated extracellular signal-regulated kinase activation","volume":"64","author":"Jimenez-Sainz","year":"2003","journal-title":"Mol Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.035899","article-title":"Chemokine (C-c motif) ligand 2 engages Ccr2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone","volume":"284","author":"Lu","year":"2009","journal-title":"J Biol Chem"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201202367","article-title":"Targeting the androgen receptor with sirna promotes prostate cancer metastasis through enhanced macrophage recruitment Via Ccl2\/Ccr2-induced Stat3 activation","volume":"5","author":"Izumi","year":"2013","journal-title":"EMBO Mol Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.3390\/ijms19061709","article-title":"Cellular and molecular mediators of bone metastatic lesions","volume":"19","author":"Battafarano","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15101","article-title":"Tumor-associated macrophage-derived transforming growth factor-beta promotes colorectal cancer progression through Hif1-Trib3 signaling","volume":"112","author":"Liu","year":"2021","journal-title":"Cancer Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20141836","article-title":"Ccl2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages","volume":"212","author":"Kitamura","year":"2015","journal-title":"J Exp Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3001","article-title":"Structural alterations of met trigger response to met kinase inhibition in lung adenocarcinoma patients","volume":"24","author":"Plenker","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"Nk cells stimulate recruitment of Cdc1 into the tumor microenvironment promoting cancer immune control","volume":"172","author":"Bottcher","year":"2018","journal-title":"Cell"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-300954","article-title":"Dnam-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ros-dependent activation of DNA-damage response: Relevance for nk-T cell interaction","volume":"117","author":"Ardolino","year":"2011","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.11","article-title":"Generation and preclinical characterization of a fc-optimized gitr-ig fusion protein for induction of nk cell reactivity against leukemia","volume":"21","author":"Schmiedel","year":"2013","journal-title":"Mol Ther"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1000546107","article-title":"Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis","volume":"107","author":"Soderstrom","year":"2010","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/35046102","article-title":"T-Cell-Mediated regulation of osteoclastogenesis by signalling cross-talk between rankl and ifn-gamma","volume":"408","author":"Takayanagi","year":"2000","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2016.09.006","article-title":"Dendritic cells and cancer immunity","volume":"37","author":"Gardner","year":"2016","journal-title":"Trends Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.06.003","article-title":"Critical role for Cd103+\/Cd141+ dendritic cells bearing Ccr7 for tumor antigen trafficking and priming of T cell immunity in melanoma","volume":"30","author":"Roberts","year":"2016","journal-title":"Cancer Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.coi.2017.01.002","article-title":"Dendritic cells in cancer: The role revisited","volume":"45","author":"Veglia","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"eabd3774","DOI":"10.1126\/sciimmunol.abd3774","article-title":"Intestinal Cdc1 drive cross-tolerance to epithelial-derived antigen Via induction of Foxp3+Cd8+ tregs","volume":"6","author":"Joeris","year":"2021","journal-title":"Sci Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3605643","article-title":"A comparative study of the T cell stimulatory and polarizing capacity of human primary blood dendritic cell subsets","volume":"2016","author":"Sittig","year":"2016","journal-title":"Mediators Inflammation"},{"key":"B54","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cell.2019.02.005","article-title":"Unleashing type-2 dendritic cells to drive protective antitumor Cd4(+) T cell immunity","volume":"177","author":"Binnewies","year":"2019","journal-title":"Cell"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.3390\/cancers14143375","article-title":"Immunophenotypic and molecular features of acute myeloid leukemia with plasmacytoid dendritic cell differentiation are distinct from blastic plasmacytoid dendritic cell neoplasm","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.11.11.15543","article-title":"Regulatory dendritic cells: New targets for cancer immunotherapy","volume":"11","author":"Shurin","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101855","article-title":"Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells","volume":"189","author":"Sawant","year":"2012","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.canlet.2006.12.012","article-title":"Ccl2\/Ccr2 pathway mediates recruitment of myeloid suppressor cells to cancers","volume":"252","author":"Huang","year":"2007","journal-title":"Cancer Lett"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.06.024","article-title":"Ccl2 promotes colorectal carcinogenesis by enhancing polymorphonuclear myeloid-derived suppressor cell population and function","volume":"12","author":"Chun","year":"2015","journal-title":"Cell Rep"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048871","article-title":"Osteoclasts in multiple myeloma are derived from gr-1+Cd11b+Myeloid-Derived suppressor cells","volume":"7","author":"Zhuang","year":"2012","journal-title":"PloS One"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4161\/onci.21990","article-title":"Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction","volume":"1","author":"Danilin","year":"2012","journal-title":"Oncoimmunology"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6305","article-title":"Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer","volume":"14","author":"Gonda","year":"2017","journal-title":"Oncol Lett"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-014-1591-2","article-title":"Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer","volume":"63","author":"Idorn","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"B64","article-title":"Increased circulating myeloid-derived suppressor cells correlate with cancer stages, interleukin-8 and -6 in prostate cancer","volume":"7","author":"Ning","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-year survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"New Engl J Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801946","article-title":"Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden","volume":"378","author":"Hellmann","year":"2018","journal-title":"N Engl J Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2016.05.016","article-title":"The role of ctla-4 and pd-1 in anti-tumor immune response and their potential efficacy against osteosarcoma","volume":"38","author":"Wang","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04522-6","article-title":"Androgen receptor activity in T cells limits checkpoint blockade efficacy","volume":"606","author":"Guan","year":"2022","journal-title":"Nature"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.11.021","article-title":"Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinoma","volume":"47","author":"Busse","year":"2011","journal-title":"Eur J Cancer"},{"key":"B70","doi-asserted-by":"publisher","first-page":"eaba7365","DOI":"10.1126\/science.aba7365","article-title":"Crispr-engineered T cells in patients with refractory cancer","volume":"367","author":"Stadtmauer","year":"2020","journal-title":"Science"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073310","article-title":"Therapeutic effects of anti-Cd115 monoclonal antibody in mouse cancer models through dual inhibition of tumor-associated macrophages and osteoclasts","volume":"8","author":"Fend","year":"2013","journal-title":"PloS One"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces il-1beta through hif-1alpha","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"key":"B73","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/biom12030392","article-title":"Therapeutic approaches targeting proteins in tumor-associated macrophages and their applications in cancers","volume":"12","author":"Wu","year":"2022","journal-title":"Biomolecules"},{"key":"B74","doi-asserted-by":"publisher","first-page":"15286","DOI":"10.1038\/s41598-020-71857-3","article-title":"Downregulation of the Ccl2\/Ccr2 and Cxcl10\/Cxcr3 axes contributes to antitumor effects in a mouse model of malignant glioma","volume":"10","author":"Shono","year":"2020","journal-title":"Sci Rep"},{"key":"B75","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.canlet.2016.11.029","article-title":"The involvement of M2 macrophage polarization inhibition in fenretinide-mediated chemopreventive effects on colon cancer","volume":"388","author":"Rong","year":"2017","journal-title":"Cancer Lett"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658681","article-title":"Fusobacterium nucleatum facilitates M2 macrophage polarization and colorectal carcinoma progression by activating Tlr4\/Nf-Kappab\/S100a9 cascade","volume":"12","author":"Hu","year":"2021","journal-title":"Front Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1126\/science.6332379","article-title":"Role of recipient Cd8+ T cell exhaustion in the rejection of adoptively transferred haploidentical nk cells","volume":"128","author":"Williams","year":"2016","journal-title":"Blood"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1126\/science.6332379","article-title":"Adoptive immunotherapy of established pulmonary metastases with lak cells and recombinant interleukin-2","volume":"225","author":"Mule","year":"1984","journal-title":"Science"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2008.23","article-title":"Activity of recombinant human interleukin-15 against tumor recurrence and 1Metastasis in mice","volume":"5","author":"Tang","year":"2008","journal-title":"Cell Mol Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: Signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14091","article-title":"Vascular endothelial growth factor (Vegf) impairs the motility and immune function of human mature dendritic cells through the vegf receptor 2-Rhoa-Cofilin1 pathway","volume":"110","author":"Long","year":"2019","journal-title":"Cancer Sci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"5408","DOI":"10.1038\/s41467-019-13368-y","article-title":"Engineering dendritic cell vaccines to improve cancer immunotherapy","volume":"10","author":"Perez","year":"2019","journal-title":"Nat Commun"},{"key":"B83","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12967-018-1507-6","article-title":"First results on survival from a Large phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma","volume":"16","author":"Liau","year":"2018","journal-title":"J Transl Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.03.012","article-title":"Expansion and activation of Cd103(+) dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic pd-L1 and braf inhibition","volume":"44","author":"Salmon","year":"2016","journal-title":"Immunity"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1182\/blood.2020007897","article-title":"Plasmacytoid dendritic cell expansion defines a distinct subset of Runx1-mutated acute myeloid leukemia - sciencedirect","volume":"137","author":"Xiao","year":"2021"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2054-x","article-title":"Epigenetic therapy inhibits metastases by disrupting premetastatic niches","volume":"579","author":"Lu","year":"2020","journal-title":"Nature"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/srep18217","article-title":"The significance of G-csf expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer","volume":"5","author":"Kawano","year":"2015","journal-title":"Sci Rep"},{"key":"B88","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1158\/2326-6066.CIR-15-0298","article-title":"Pretreatment immune status correlates with progression-free survival in chemotherapy-treated metastatic colorectal cancer patients","volume":"4","author":"Tada","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-3104","article-title":"Clinical significance of circulating Cd33+Cd11b+Hla-dr- myeloid cells in patients with stage iv melanoma treated with ipilimumab","volume":"22","author":"Sadefeldman","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2412","article-title":"Baseline peripheral blood biomarkers associated with clinical outcome of advanced melanoma patients treated with ipilimumab","volume":"22","author":"Martens","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13337","article-title":"Contrasting effects of cyclophosphamide on anti-Ctl-Associated protein 4 blockade therapy in two mouse tumor models","volume":"108","author":"Iida","year":"2017","journal-title":"Cancer Sci"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2016.10.003","article-title":"Immunosuppressive myeloid cells' blockade in the glioma microenvironment enhances the efficacy of immune-stimulatory gene therapy","volume":"25","author":"Kamran","year":"2017","journal-title":"Mol Ther"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0213","article-title":"Targeting immune suppression with Pde5 inhibition in end-stage multiple myeloma","volume":"2","author":"Noonan","year":"2014","journal-title":"Cancer Immunol Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1019864\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T06:49:46Z","timestamp":1664434186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1019864\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":93,"alternative-id":["10.3389\/fendo.2022.1019864"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1019864","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"article-number":"1019864"}}